Back to search
Chemotherapy-induced Thrombocytopenia (CIT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chemotherapy-induced Thrombocytopenia (CIT) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chemotherapy-induced Thrombocytopenia (CIT) trials you may qualify forThe goal of this clinical trial is to evaluate the efficacy and safety of romiplostim N01 in treating chemotherapy-induced thrombocytopenia (CIT) in children an…
This trial is a single-arm, prospective clinical study aimed at evaluating the efficacy and safety of hetrombopag in preventing chemotherapy-induced thrombocyto…
The goal of this clinical trial is to to assess the efficacy of romiplostim as a supportive care measure in patients with a new diagnosis of Ewing sarcoma recei…
The purpose of this study is to compare the efficacy of two study drugs, Avatrobopag versus placebo, to treat persistent Chemotherapy-Induced Thrombocytopenia (…
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, Preliminary Efficacy and Pharmacokinetics of SCB-219M in the patients with chemot…